GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ambalal Sarabhai Enterprises Ltd (BOM:500009) » Definitions » Sloan Ratio %

Ambalalrabhai Enterprises (BOM:500009) Sloan Ratio % : 0.00% (As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Ambalalrabhai Enterprises Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Ambalalrabhai Enterprises's Sloan Ratio for the quarter that ended in Dec. 2024 was 0.00%.

As of Dec. 2024, Ambalalrabhai Enterprises has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Ambalalrabhai Enterprises Sloan Ratio % Historical Data

The historical data trend for Ambalalrabhai Enterprises's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ambalalrabhai Enterprises Sloan Ratio % Chart

Ambalalrabhai Enterprises Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.17 10.27 13.31 9.16 0.83

Ambalalrabhai Enterprises Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ambalalrabhai Enterprises's Sloan Ratio %

For the Drug Manufacturers - Specialty & Generic subindustry, Ambalalrabhai Enterprises's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ambalalrabhai Enterprises's Sloan Ratio % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ambalalrabhai Enterprises's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Ambalalrabhai Enterprises's Sloan Ratio % falls into.


;
;

Ambalalrabhai Enterprises Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Ambalalrabhai Enterprises's Sloan Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Sloan Ratio=(Net Income (A: Mar. 2024 )-Cash Flow from Operations (A: Mar. 2024 )
-Cash Flow from Investing (A: Mar. 2024 ))/Total Assets (A: Mar. 2024 )
=(56.807-47.173
--11.256)/2502.281
=0.83%

Ambalalrabhai Enterprises's Sloan Ratio for the quarter that ended in Dec. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2024 )
=(134.868-0
-0)/0
=%

Ambalalrabhai Enterprises's Net Income for the trailing twelve months (TTM) ended in Dec. 2024 was 82.881 (Mar. 2024 ) + 3.471 (Jun. 2024 ) + 26.199 (Sep. 2024 ) + 22.317 (Dec. 2024 ) = ₹135 Mil.
Ambalalrabhai Enterprises's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2024 was 0 (Mar. 2024 ) + 0 (Jun. 2024 ) + 0 (Sep. 2024 ) + 0 (Dec. 2024 ) = ₹0 Mil.
Ambalalrabhai Enterprises's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2024 was 0 (Mar. 2024 ) + 0 (Jun. 2024 ) + 0 (Sep. 2024 ) + 0 (Dec. 2024 ) = ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ambalalrabhai Enterprises  (BOM:500009) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2024, Ambalalrabhai Enterprises has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Ambalalrabhai Enterprises Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Ambalalrabhai Enterprises's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ambalalrabhai Enterprises Business Description

Traded in Other Exchanges
N/A
Address
Mirzapur Road, Shanti Sadan, Ahmedabad, GJ, IND, 380001
Ambalal Sarabhai Enterprises Ltd is an India-based company engaged in the manufacturing and marketing of Drugs and Formulation. Its operating segments are Pharmaceutical Products. It serves domestic as well as International markets.

Ambalalrabhai Enterprises Headlines

No Headlines